Drug Profile
Pibrozelesin
Alternative Names: DC 113; DC 88A; DUMs; Duocarmycin; KW 2189; Pibrozelesin hydrobromideLatest Information Update: 20 Oct 2021
Price :
$50
*
At a glance
- Originator Kyowa Hakko
- Developer GlaxoSmithKline; Janssen L.P.; Kyowa Hakko
- Class Cytostatic antibiotics; Small molecules
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Gastric cancer; Pancreatic cancer; Renal cancer